Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (250 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 29 Dec 2015 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Tata India Consumer Fund |
|---|---|
| 29 Dec 2015 | ₹100.00 |
| 17 Nov 2016 | ₹103.07 |
| 07 Oct 2017 | ₹165.05 |
| 27 Aug 2018 | ₹202.44 |
| 17 Jul 2019 | ₹171.23 |
| 05 Jun 2020 | ₹172.30 |
| 25 Apr 2021 | ₹229.55 |
| 14 Mar 2022 | ₹270.55 |
| 01 Feb 2023 | ₹290.14 |
| 22 Dec 2023 | ₹403.08 |
| 10 Nov 2024 | ₹508.52 |
| 30 Sep 2025 | ₹511.35 |
| 20 Aug 2026 | ₹546.67 |
| Metric | Tata · Direct · IDCW NAV ₹54.93 Very High risk ★★★★☆ | Category median Sectoral/ Thematic · 250 funds |
|---|---|---|
| +3.92% | +5.11% | |
| +15.91% | +13.02% | |
| +15.19% | +11.14% | |
| +17.23% | +12.26% | |
| +17.31% | +11.82% | |
| +14.81% | — | |
| +17.35% | +14.62% | |
| +17.88% | +12.95% | |
| +17.56% | +13.24% | |
| Risk | ||
| 14.21% | 15.88% | |
| 0.66 | 0.35 | |
| 0.93 | 0.47 | |
| -32.46% | -25.18% | |
| Nifty 500 | — | |
| +3.75% | +1.40% | |
| 0.93 | 0.98 | |
| 102.9% | 101.5% | |
| 83.5% | 97.0% | |
| 0.92% | 1.14% | |
| ₹2,520Cr | ₹1,162Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 18% | 45% | |
| Sonam Udasi · 10.4y | — | |
| 29 Dec 2015 | — | |
| 35 | — | |
| 50.8% | — | |
| 3.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.